Olkkola K T, Maunuksela E L, Korpela R
Department of Clinical Pharmacology, University of Helsinki, Finland.
Pharmacol Toxicol. 1989 Aug;65(2):157-60. doi: 10.1111/j.1600-0773.1989.tb01147.x.
The disposition of indomethacin was studied in children aged one to four years. Indomethacin 0.35 mg/kg was administered as an intravenous infusion during 15 min. Venous blood samples were collected until 24 hr after infusion. Serum indomethacin was determined with gas chromatography. Using a non-linear regression analysis, the individual data were fitted by a two-compartment open mammillary model with central elimination. Calculated pharmacokinetic parameters were (mean +/- SD); alpha half-life 25.2 +/- 11.3 min; beta half-life 366 +/- 295 min; steady-state volume of distribution 0.74 +/- 0.75 l/kg; volume during elimination phase 1.53 +/- 1.27 l/kg; total body clearance 3.2 +/- 1.7 ml/min./kg. Accordingly, with respect to the pharmacokinetics of indomethacin, children seem to mature early, not later than at the age of one year.
对1至4岁儿童的吲哚美辛处置情况进行了研究。以0.35毫克/千克的吲哚美辛在15分钟内进行静脉输注。在输注后直至24小时采集静脉血样。采用气相色谱法测定血清吲哚美辛。通过非线性回归分析,个体数据用具有中央消除的二室开放乳头状模型进行拟合。计算得到的药代动力学参数为(平均值±标准差):α半衰期25.2±11.3分钟;β半衰期366±295分钟;稳态分布容积0.74±0.75升/千克;消除相容积1.53±1.27升/千克;全身清除率3.2±1.7毫升/分钟/千克。因此,就吲哚美辛的药代动力学而言,儿童似乎成熟较早,不晚于1岁。